Abstract
The 2016 Canadian Cardiovascular Society (CCS) Guidelines for the management of Dyslipidemia recommend to consider a target of <1.8mmol/L (70mg/dL) for subjects with an acute coronary syndrome (ACS) within the past 3 months. The AMI-OPTIMA study was a cluster randomized trial evaluating knowledge
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
